There are 2934 resources available
1292 - Results of the randomized, Placebo (PL)-controlled Phase II study evaluating the efficacy and safety of Regorafenib (REG) in patients (pts) with locally advanced (LA) or metastatic relapsed Chondrosarcoma (CS), on behalf of the French Sarcoma Group (FSG) and Unicancer
Presenter: Florence Duffaud
Session: Proffered Paper - Sarcoma
Resources:
Abstract
Slides
Webcast
4794 - INVICTUS: A Phase 3, INterVentional, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ripretinib as _4th-Line Therapy In Patients With AdvanCed Gastrointestinal Stromal TUmorS (GIST) Who have Received Treatment With Prior Anticancer Therapies (NCT03353753)
Presenter: Margaret von Mehren
Session: Proffered Paper - Sarcoma
Resources:
Abstract
Slides
Webcast
EONS - Occupational safety
Presenter: Johan De Munter
Session: EONS 12: Creating a safety culture in cancer care
Resources:
Slides
Webcast
EONS - ONS Guidelines on safety
Presenter: Lisa Kennedy Sheldon
Session: EONS 12: Creating a safety culture in cancer care
Resources:
Slides
2nd vote and conclusions
Presenter: Jean Bourhis
Session: Treatment de-escalation in HPV+ oropharyngeal cancer?
Resources:
Slides
Webcast
Introduction and 1st vote
Presenter: Jean Bourhis
Session: Treatment de-escalation in HPV+ oropharyngeal cancer?
Resources:
Slides
Webcast
Pro
Presenter: Christian Simon
Session: Treatment de-escalation in HPV+ oropharyngeal cancer?
Resources:
Slides
Webcast
Contra
Presenter: Hisham Mehanna
Session: Treatment de-escalation in HPV+ oropharyngeal cancer?
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: Chris Parker
Session: Treatment of pelvic node-positive prostate cancer
Resources:
Slides
Webcast
Advances in pelvic nodal radiotherapy
Presenter: Gert De Meerleer
Session: Treatment of pelvic node-positive prostate cancer
Resources:
Slides
Webcast